Virus injection targets Hard-to-Treat cancers in early trial
Disease control
Terminated
This early-stage trial tests a new treatment called BS006, a virus designed to infect and destroy cancer cells. It is given as an injection directly into tumors in people with advanced solid tumors that have not responded to other treatments. The main goals are to check safety, f…
Phase: PHASE1 • Sponsor: Binhui Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:43 UTC